Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
Masimo's (MASI) Preliminary Q2 Revenues Dampened by Lower Sales
01:35pm, Tuesday, 18'th Jul 2023
Masimo's (MASI) second-quarter 2023 results are likely to have been dampened by the postponement of orders and increased hospital labor costs, among others.
Masimo shares plummet on weak 2Q sales forecast
08:40am, Tuesday, 18'th Jul 2023
Masimo shares plunged almost 30% in pre-market trading on Tuesday after it reported preliminary second quarter revenue that came in far below expectations. The Irvine, California-based medical technol
Pinterest stock advances, Masimo shares slump on outlook and other stocks on the move
05:34am, Tuesday, 18'th Jul 2023
Shares of Pinterest Inc. PINS, +1.53% were gaining 4% after an Evercore ISI analyst moved to a bullish stance, cheering better advertising-market conditions and improvements made by Chief Executive Bi
Weaker sales due to fewer hospital patients take down shares of Masimo
05:21pm, Monday, 17'th Jul 2023
Shares of Masimo Corp. MASI, -1.61% on Monday tumbled 25% after hours after the hospital-equipment maker forecast second-quarter sales that were far below estimates and tempered sales expectations for
Medical device maker Masimo forecasts weak quarterly revenue
04:52pm, Monday, 17'th Jul 2023
Masimo Corp on Monday reported preliminary second-quarter results below analysts' estimates, sending the medical device maker's shares down about 20% in after-market trading.
Three Reasons to Add Masimo (MASI) Stock to Your Portfolio
12:03pm, Tuesday, 27'th Jun 2023
Masimo's (MASI) solid product suite raises optimism about the stock.
Masimo's (MASI) W1 to Boost Virtual Care in Preoperative Patients
12:01pm, Monday, 26'th Jun 2023
Masimo's (MASI) W1 advanced health-tracking watch is expected to provide better insights into pre-operative patients' heart rate variability data and improve pre-habilitation.
Masimo's (MASI) Launch to Serve the Personalized Hearables Market
12:36pm, Thursday, 22'nd Jun 2023
Masimo's (MASI) new product offerings are expected to enable it to expand its footprint in the personalized hearables market.
Activist Politan gets fresh backing for boardroom challenge at Masimo
03:07pm, Thursday, 15'th Jun 2023
Two influential proxy advisory firms are backing activist Politan Capital Management's quest for two board seats at Masimo , arguing the candidates would bring experience and perspective to the medica
Masimo (MASI) Inks Deals for Patient Monitoring Technologies
08:32am, Thursday, 15'th Jun 2023
Masimo's (MASI) advanced monitoring technologies and solutions attract new customers looking for better patient care, using remote and centralized surveillance, and seamless data transfer to EMRs.
ISS backs both Politan directors in boardroom challenge at Masimo -report
10:13am, Tuesday, 13'th Jun 2023
Proxy advisory firm Institutional Shareholder Services (ISS) on Tuesday backed Politan Capital Management in a boardroom challenge at medical device maker Masimo Corp by recommending shareholders elec
Masimo's (MASI) New FDA Approval to Boost Patient Monitoring
01:49pm, Wednesday, 07'th Jun 2023
Masimo's (MASI) Radius VSM is expected to equip any hospital bed with comprehensive monitoring and offer more personalized care without additional bedside equipment.
Masimo: Staying Neutral Following Unchanged Guidance And Recent Developments
01:03pm, Monday, 05'th Jun 2023
Positive earnings surprises for Masimo Corporation in FY 2023 are less likely, taking into account Masimo's unchanged full-year financial guidance. It will be tough for Masimo's shares to witness a me
Masimo's (MASI) Platform Expansion to Boost Patient Monitoring
11:32am, Thursday, 25'th May 2023
Masimo's (MASI) latest expansion to its HEOS platform will likely revolutionize health and wellness tracking by allowing connected care as consumers become tetherless and smartphone-less.
3 Medical Instruments Stocks to Buy Amid Industry Challenges
10:46am, Thursday, 25'th May 2023
The Zacks Medical - Instruments industry is growing on rising demand for digital health. HOLX, MASI and ITGR are set to gain the most.
